Neopharmtech India Private Limited
About Neopharmtech India Private Limited
Data last updated:
Neopharmtech India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72900TG2019PTC132163.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jyothi Muppavarapu Rajendraprasad and Charanu Kumar Vuddanti.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 109 Bhavya Majestic Enclave Madhavanagar Colony Miyapur, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.65 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net loss of ₹22.61 Lakh (net margin -339.9%) and EBITDA of -₹22.62 Lakh (EBITDA margin -340.1%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 19% over five years.
Company details
Contact details
Neopharmtech India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address# 109 Bhavya Majestic Enclave Madhavanagar Colony Miyapur, Hyderabad, Telangana, India – 500049
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Neopharmtech India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neopharmtech India is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Neopharmtech India Private Limited, buy the company report.
Financials of Neopharmtech India Private Limited
FY 2025 filings availableNeopharmtech India Private Limited reported revenue of ₹6.65 Lakh (down 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 27% fall in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹22.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹22.61 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -340.1% | ||||
| Net Profit Margin | -339.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neopharmtech India Private Limited, buy the company report.
Board of directors of Neopharmtech India Private Limited
Neopharmtech India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyothi Muppavarapu Rajendraprasad Also directs: Beadlets Pharma Private Limited, Vaipra Pharma Private Limited | Director | 20 Apr 2019 | 7 Years 6 Months | Current |
| Charanu Kumar Vuddanti | Director | 20 Apr 2019 | 7 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Neopharmtech India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neopharmtech India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neopharmtech India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neopharmtech India Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Pulla Reddy Duggirala ceased to be Director on 26 Oct 2022.
Frequently asked questions
Neopharmtech India is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 April 2019 (7+ years old) and is registered under CIN U72900TG2019PTC132163.
Neopharmtech India has 2 current directors:
- Jyothi Muppavarapu Rajendraprasad - Director
- Charanu Kumar Vuddanti - Director
The latest financial statements of Neopharmtech India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Neopharmtech India is U72900TG2019PTC132163. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neopharmtech India was incorporated on 20 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Pulla Reddy Duggirala ceased to be Director on 26 Oct 2022. Charanu Kumar Vuddanti was appointed as Director on 20 Apr 2019. Jyothi Muppavarapu Rajendraprasad was appointed as Director on 20 Apr 2019.
The registered office of Neopharmtech India is at # 109 Bhavya Majestic Enclave Madhavanagar Colony Miyapur, Hyderabad, Telangana, India – 500049.
Neopharmtech India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Neopharmtech India can be reached at its registered office: # 109 Bhavya Majestic Enclave Madhavanagar Colony Miyapur, Hyderabad, Telangana, India – 500049.
Neopharmtech India is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
